Reference
- Ackermann H. BIAS Biometrische Analyse von Stichproben. Epsilon-Verlag, Hochheim-Darmstadt 1997
- Bachmann S, Peters J, Engler E. Transgenic rats carrying the mouse renin gene—morphological characterization of a low-renin hypertension model. Kidney Int. 1992; 41: 24–36
- Barrett G L, Mullins J J. Studies on blood pressure regulation in hypertensive ren-2 transgenic rats. Kidney Int. 1992; 41: S125–28
- Hauptfleisch S, Schummer B, Lemmer B. Expression of c-fos messenger-RNA involved in the regulation of blood pressure in normotensive and transgenic hypertensive rats [abstract]. Naunyn-Schmiedeberg's Arch Pharmacol. 1998; 357: R17, (Suppl)
- Lemmer B, Mattes A, Böhm M. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension. 1993; 22: 97–101
- Lemmer B, Witte K, Makabe T. Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats. J Cardiovasc Pharmacol. 1994; 23: 311–14
- Middeke M, Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Br Med J. 1994; 308: 630–32
- Moore R Y. Chemical neuroanatomy of the mammalian circadian system. Physiology and pharmacology of biological rhythms. Handbook of Experimental Pharmacology, P H Redfern, B Lemmer. Springer Verlag, Berlin 1997; Vol. 125: 79–94
- Moriguchi A, Brosnihan K B, Kumagai H. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994; 266: R1273–78
- Moriguchi A, Ferrario C M, Brosnihan K B. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am J Physiol. 1994; 267: R786–91
- Mullins J J, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 renin gene. Nature 1990; 344: 541–44
- Nakajima T, Yamada T, Setoguchi M. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1992; 19: 102–7
- Schnecko A, Witte K, Lemmer B. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats. J Cardiovasc Pharmacol. 1995; 26: 214–21
- Senanayake P D, Moriguchi A, Kumagai H. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994; 15: 919–26
- Springate J E, Feld L G, Ganten D. Renal function in hypertensive rats transgenic for mouse renin gene. Am J Physiol. 1994; 266: F731–37
- Struijkerboudier H AJ, Vanessen H, Fazzi G. Disproportional arterial hypertrophy in hypertensive mRen-2 transgenic rats. Hypertension. 1996; 28: 779–84
- Tokita Y, Franco-Saenz R, Reimann E M. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension. 1994; 23: 422–27
- Vhiant M, Whitworth C E, McNard J. Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats. Am J Hypertens. 1995; 8: 1167–76
- Villarreal F J, Mackenna D A, Omens J H. Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension. 1995; 25: 98–104
- Witte K, Lemmer B. Free-running rhythms in blood pressure and heart rate in normotensive and transgenic hypertensive rats. Chronobiol Int. 1995; 12: 237–47
- Witte K, Schnecko A, Buijs R M. Effects of SCN-lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. Chronobiol Int. 1998; 15: 135–45
- Witte K, Zuther P, Lemmer B. Analysis of telemetric time series data for periodic components using DQ-FIT. Chronobiol Int. 1997; 14: 561–74
- Zhao Y, Bader M, Kreutz R. Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27. Am J Physiol. 1993; 265: E699–E707
- Zuther P, Witte K, Lemmer B. ABPM-FIT and CV-SORT: an easy-to-use software package for detailed analyses of data from ambulatory blood pressure monitoring. Blood Press Monit. 1996; 1: 347–54